Skip to main content
Top
Published in: Virology Journal 1/2009

Open Access 01-12-2009 | Research

Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities

Authors: Nongluk Sriwilaijaroen, Prapon Wilairat, Hiroaki Hiramatsu, Tadanobu Takahashi, Takashi Suzuki, Morihiro Ito, Yasuhiko Ito, Masato Tashiro, Yasuo Suzuki

Published in: Virology Journal | Issue 1/2009

Login to get access

Abstract

Background

Influenza virus infection causes significant morbidity and mortality and has marked social and economic impacts throughout the world. The influenza surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA), act cooperatively to support efficient influenza A virus replication and provide the most important targets for anti-influenza chemotherapy. In this study, povidone-iodine (PVP-I), which has a broad-spectrum microbicidal property, was examined for its inhibitory effects against influenza virus infection in MDCK cells and the mechanisms of PVP-I action on HA and NA were revealed.

Results

Results obtained using a novel fluorescence- and chromogenic-based plaque inhibition assay showed that 1.56 mg/ml PVP-I inhibited infections in MDCK cells of human (8 strains) and avian (5 strains) influenza A viruses, including H1N1, H3N2, H5N3 and H9N2, from 23.0–97.5%. A sialidase inhibition assay revealed that PVP-I inhibited N1, N2 and N3 neuraminidases with IC50 values of 9.5–212.1 μg/ml by a mixed-type inhibition mechanism. Receptor binding inhibition and hemagglutinin inhibition assays indicated that PVP-I affected viral hemagglutinin rather than host-specific sialic acid receptors.

Conclusion

Mechanisms of reduction of viral growth in MDCK cells by PVP-I involve blockade of viral attachment to cellular receptors and inhibition of viral release and spread from infected cells. Therefore, PVP-I is useful to prevent infection and limit spread of human and avian influenza viruses.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hampson AW, Mackenzie JS: The influenza viruses. Med J Aust 2006, 185: S39-43.PubMed Hampson AW, Mackenzie JS: The influenza viruses. Med J Aust 2006, 185: S39-43.PubMed
2.
go back to reference Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, Rimmelzwaan GF, Olsen B, Osterhaus AD: Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005, 79: 2814-2822. 10.1128/JVI.79.5.2814-2822.2005PubMedCentralCrossRefPubMed Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, Rimmelzwaan GF, Olsen B, Osterhaus AD: Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005, 79: 2814-2822. 10.1128/JVI.79.5.2814-2822.2005PubMedCentralCrossRefPubMed
3.
go back to reference Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, Kobasa D, Kawaoka Y: Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol 2000, 74: 6015-6020. 10.1128/JVI.74.13.6015-6020.2000PubMedCentralCrossRefPubMed Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, Kobasa D, Kawaoka Y: Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol 2000, 74: 6015-6020. 10.1128/JVI.74.13.6015-6020.2000PubMedCentralCrossRefPubMed
4.
go back to reference Guo CT, Wong CH, Kajimoto T, Miura T, Ida Y, Juneja LR, Kim MJ, Masuda H, Suzuki T, Suzuki Y: Synthetic sialylphosphatidylethanolamine derivatives bind to human influenza A viruses and inhibit viral infection. Glycoconj J 1998, 15: 1099-1108. 10.1023/A:1006961912465CrossRefPubMed Guo CT, Wong CH, Kajimoto T, Miura T, Ida Y, Juneja LR, Kim MJ, Masuda H, Suzuki T, Suzuki Y: Synthetic sialylphosphatidylethanolamine derivatives bind to human influenza A viruses and inhibit viral infection. Glycoconj J 1998, 15: 1099-1108. 10.1023/A:1006961912465CrossRefPubMed
5.
go back to reference Matrosovich M, Klenk HD: Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding. Rev Med Virol 2003, 13: 85-97. 10.1002/rmv.372CrossRefPubMed Matrosovich M, Klenk HD: Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding. Rev Med Virol 2003, 13: 85-97. 10.1002/rmv.372CrossRefPubMed
6.
go back to reference Spevak W, Nagy JO, Charych DH, Schaefer ME, Gilbert JH, Bednarski MD: Polymerized liposomes containing C -glycosides of sialic acid are potent inhibitors of influenza virus in vitro infectivity. J Am Chem Soc 1993, 115: 1146-1147. 10.1021/ja00056a047CrossRef Spevak W, Nagy JO, Charych DH, Schaefer ME, Gilbert JH, Bednarski MD: Polymerized liposomes containing C -glycosides of sialic acid are potent inhibitors of influenza virus in vitro infectivity. J Am Chem Soc 1993, 115: 1146-1147. 10.1021/ja00056a047CrossRef
7.
go back to reference Govorkova EA, Leneva IA, Goloubeva OG, Bush K, Webster RG: Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses. Antimicrob Agents Chemother 2001, 45: 2723-2732. 10.1128/AAC.45.10.2723-2732.2001PubMedCentralCrossRefPubMed Govorkova EA, Leneva IA, Goloubeva OG, Bush K, Webster RG: Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses. Antimicrob Agents Chemother 2001, 45: 2723-2732. 10.1128/AAC.45.10.2723-2732.2001PubMedCentralCrossRefPubMed
8.
go back to reference Honda T, Masuda T, Yoshida S, Arai M, Kobayashi Y, Yamashita M: Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives. Bioorg Med Chem Lett 2002, 12: 1921-1924. 10.1016/S0960-894X(02)00328-1CrossRefPubMed Honda T, Masuda T, Yoshida S, Arai M, Kobayashi Y, Yamashita M: Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives. Bioorg Med Chem Lett 2002, 12: 1921-1924. 10.1016/S0960-894X(02)00328-1CrossRefPubMed
9.
go back to reference Shie JJ, Fang JM, Wang SY, Tsai KC, Cheng YS, Yang AS, Hsiao SC, Su CY, Wong CH: Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity. J Am Chem Soc 2007, 129: 11892-11893. 10.1021/ja073992iCrossRefPubMed Shie JJ, Fang JM, Wang SY, Tsai KC, Cheng YS, Yang AS, Hsiao SC, Su CY, Wong CH: Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity. J Am Chem Soc 2007, 129: 11892-11893. 10.1021/ja073992iCrossRefPubMed
10.
go back to reference von Itzstein M: The war against influenza: discovery and development of sialidase inhibitors. Nat Rev Drug Discov 2007, 6: 967-974. 10.1038/nrd2400CrossRefPubMed von Itzstein M: The war against influenza: discovery and development of sialidase inhibitors. Nat Rev Drug Discov 2007, 6: 967-974. 10.1038/nrd2400CrossRefPubMed
11.
go back to reference Yun NE, Linde NS, Zacks MA, Barr IG, Hurt AC, Smith JN, Dziuba N, Holbrook MR, Zhang L, Kilpatrick JM, et al.: Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1). Virology 2008, 374: 198-209. 10.1016/j.virol.2007.12.029PubMedCentralCrossRefPubMed Yun NE, Linde NS, Zacks MA, Barr IG, Hurt AC, Smith JN, Dziuba N, Holbrook MR, Zhang L, Kilpatrick JM, et al.: Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1). Virology 2008, 374: 198-209. 10.1016/j.virol.2007.12.029PubMedCentralCrossRefPubMed
12.
go back to reference Guo CT, Sun XL, Kanie O, Shortridge KF, Suzuki T, Miyamoto D, Hidari KI, Wong CH, Suzuki Y: An O -glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza viruses. Glycobiology 2002, 12: 183-190. 10.1093/glycob/12.3.183CrossRefPubMed Guo CT, Sun XL, Kanie O, Shortridge KF, Suzuki T, Miyamoto D, Hidari KI, Wong CH, Suzuki Y: An O -glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza viruses. Glycobiology 2002, 12: 183-190. 10.1093/glycob/12.3.183CrossRefPubMed
13.
go back to reference von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, Van Phan T, Smythe ML, White HF, Oliver SW, et al.: Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 1993, 363: 418-423. 10.1038/363418a0CrossRefPubMed von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, Van Phan T, Smythe ML, White HF, Oliver SW, et al.: Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 1993, 363: 418-423. 10.1038/363418a0CrossRefPubMed
14.
go back to reference Li W, Escarpe PA, Eisenberg EJ, Cundy KC, Sweet C, Jakeman KJ, Merson J, Lew W, Williams M, Zhang L, et al.: Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother 1998, 42: 647-653.PubMedCentralCrossRefPubMed Li W, Escarpe PA, Eisenberg EJ, Cundy KC, Sweet C, Jakeman KJ, Merson J, Lew W, Williams M, Zhang L, et al.: Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother 1998, 42: 647-653.PubMedCentralCrossRefPubMed
15.
go back to reference Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, et al.: Avian flu: isolation of drug-resistant H5N1 virus. Nature 2005, 437: 1108. 10.1038/4371108aCrossRefPubMed Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, et al.: Avian flu: isolation of drug-resistant H5N1 virus. Nature 2005, 437: 1108. 10.1038/4371108aCrossRefPubMed
16.
go back to reference Mishin VP, Hayden FG, Gubareva LV: Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob Agents Chemother 2005, 49: 4515-4520. 10.1128/AAC.49.11.4515-4520.2005PubMedCentralCrossRefPubMed Mishin VP, Hayden FG, Gubareva LV: Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob Agents Chemother 2005, 49: 4515-4520. 10.1128/AAC.49.11.4515-4520.2005PubMedCentralCrossRefPubMed
17.
go back to reference Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, Walker PA, Skehel JJ, Martin SR, Hay AJ, Gamblin SJ: Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 2008, 453: 1258-1261. 10.1038/nature06956CrossRefPubMed Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, Walker PA, Skehel JJ, Martin SR, Hay AJ, Gamblin SJ: Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 2008, 453: 1258-1261. 10.1038/nature06956CrossRefPubMed
18.
20.
go back to reference Zamora JL: Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg 1986, 151: 400-406. 10.1016/0002-9610(86)90477-0CrossRefPubMed Zamora JL: Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg 1986, 151: 400-406. 10.1016/0002-9610(86)90477-0CrossRefPubMed
21.
go back to reference Lacey RW, Catto A: Action of povidone-iodine against methicillin-sensitive and -resistant cultures of Staphylococcus aureus . Postgrad Med J 1993,69(Suppl 3):S78-83.PubMed Lacey RW, Catto A: Action of povidone-iodine against methicillin-sensitive and -resistant cultures of Staphylococcus aureus . Postgrad Med J 1993,69(Suppl 3):S78-83.PubMed
22.
go back to reference Mycock G: Methicillin/antiseptic-resistant Staphylococcus aureus . Lancet 1985, 2: 949-950. 10.1016/S0140-6736(85)90881-5CrossRefPubMed Mycock G: Methicillin/antiseptic-resistant Staphylococcus aureus . Lancet 1985, 2: 949-950. 10.1016/S0140-6736(85)90881-5CrossRefPubMed
23.
go back to reference Boudouma M, Enjalbert L, Didier J: A simple method for the evaluation of antiseptic and disinfectant virucidal activity. J Virol Methods 1984, 9: 271-276. 10.1016/0166-0934(84)90052-1CrossRefPubMed Boudouma M, Enjalbert L, Didier J: A simple method for the evaluation of antiseptic and disinfectant virucidal activity. J Virol Methods 1984, 9: 271-276. 10.1016/0166-0934(84)90052-1CrossRefPubMed
24.
go back to reference Woodbridge P: The use of betadine antiseptic paint in the treatment of Herpes simplex and Herpes Zoster. J Int Med Res 1977, 5: 378-381.CrossRefPubMed Woodbridge P: The use of betadine antiseptic paint in the treatment of Herpes simplex and Herpes Zoster. J Int Med Res 1977, 5: 378-381.CrossRefPubMed
25.
go back to reference Harbison MA, Hammer SM: Inactivation of human immunodeficiency virus by betadine products and chlorhexidine. J Acquir Immune Defic Syndr 1989, 2: 16-20.PubMed Harbison MA, Hammer SM: Inactivation of human immunodeficiency virus by betadine products and chlorhexidine. J Acquir Immune Defic Syndr 1989, 2: 16-20.PubMed
26.
go back to reference Kawana R, Kitamura T, Nakagomi O, Matsumoto I, Arita M, Yoshihara N, Yanagi K, Yamada A, Morita O, Yoshida Y, et al.: Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology 1997,195(Suppl 2):29-35.CrossRefPubMed Kawana R, Kitamura T, Nakagomi O, Matsumoto I, Arita M, Yoshihara N, Yanagi K, Yamada A, Morita O, Yoshida Y, et al.: Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology 1997,195(Suppl 2):29-35.CrossRefPubMed
27.
go back to reference Ito H, Ito T, Hikida M, Yashiro J, Otsuka A, Kida H, Otsuki K: Outbreak of highly pathogenic avian influenza in Japan and anti-influenza virus activity of povidone-iodine products. Dermatology 2006,212(Suppl 1):115-118. 10.1159/000089210CrossRefPubMed Ito H, Ito T, Hikida M, Yashiro J, Otsuka A, Kida H, Otsuki K: Outbreak of highly pathogenic avian influenza in Japan and anti-influenza virus activity of povidone-iodine products. Dermatology 2006,212(Suppl 1):115-118. 10.1159/000089210CrossRefPubMed
28.
go back to reference Wutzler P, Sauerbrei A, Klocking R, Brogmann B, Reimer K: Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine. Antiviral Res 2002, 54: 89-97. 10.1016/S0166-3542(01)00213-3CrossRefPubMed Wutzler P, Sauerbrei A, Klocking R, Brogmann B, Reimer K: Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine. Antiviral Res 2002, 54: 89-97. 10.1016/S0166-3542(01)00213-3CrossRefPubMed
29.
go back to reference Suzuki Y: Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull 2005, 28: 399-408. 10.1248/bpb.28.399CrossRefPubMed Suzuki Y: Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull 2005, 28: 399-408. 10.1248/bpb.28.399CrossRefPubMed
30.
go back to reference Gottardi W: Iodine and iodine compounds. In Disinfection, sterilization, and preservation. 4th edition. Edited by: Block S. Philadelphia: Lea & Febiger; 1991:152-165. Gottardi W: Iodine and iodine compounds. In Disinfection, sterilization, and preservation. 4th edition. Edited by: Block S. Philadelphia: Lea & Febiger; 1991:152-165.
31.
go back to reference Gottardi W: Iodine and disinfection: theoretical study on mode of action, efficiency, stability, and analytical aspects in the aqueous system. Arch Pharm (Weinheim) 1999, 332: 151-157. 10.1002/(SICI)1521-4184(19995)332:5<158::AID-ARDP158>3.0.CO;2-NCrossRef Gottardi W: Iodine and disinfection: theoretical study on mode of action, efficiency, stability, and analytical aspects in the aqueous system. Arch Pharm (Weinheim) 1999, 332: 151-157. 10.1002/(SICI)1521-4184(19995)332:5<158::AID-ARDP158>3.0.CO;2-NCrossRef
32.
go back to reference Selvaggi G, Monstrey S, Van Landuyt K, Hamdi M, Blondeel P: The role of iodine in antisepsis and wound management: a reappraisal. Acta Chir Belg 2003, 103: 241-247.PubMed Selvaggi G, Monstrey S, Van Landuyt K, Hamdi M, Blondeel P: The role of iodine in antisepsis and wound management: a reappraisal. Acta Chir Belg 2003, 103: 241-247.PubMed
33.
34.
go back to reference Ripa S, Bruno N, Reder RF, Casillis R, Roth RI: Clinical applications of povidone-iodine as a topical antimicrobial. In Handbook of topical antimicrobials: industrial applications in consumer products and pharmaceuticals. Edited by: Paulson DS. New York: Marcel Dekker; 2003:77-98. Ripa S, Bruno N, Reder RF, Casillis R, Roth RI: Clinical applications of povidone-iodine as a topical antimicrobial. In Handbook of topical antimicrobials: industrial applications in consumer products and pharmaceuticals. Edited by: Paulson DS. New York: Marcel Dekker; 2003:77-98.
35.
go back to reference Rello S, Stockert JC, Moreno V, Gamez A, Pacheco M, Juarranz A, Canete M, Villanueva A: Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments. Apoptosis 2005, 10: 201-208. 10.1007/s10495-005-6075-6CrossRefPubMed Rello S, Stockert JC, Moreno V, Gamez A, Pacheco M, Juarranz A, Canete M, Villanueva A: Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments. Apoptosis 2005, 10: 201-208. 10.1007/s10495-005-6075-6CrossRefPubMed
36.
go back to reference Cointe D, Leroy Y, Chirat F: Determination of the sialylation level and of the ratio alpha-(2→3)/alpha-(2→6) sialyl linkages of N -glycans by methylation and GC/MS analysis. Carbohydr Res 1998, 311: 51-59. 10.1016/S0008-6215(98)00196-7CrossRefPubMed Cointe D, Leroy Y, Chirat F: Determination of the sialylation level and of the ratio alpha-(2→3)/alpha-(2→6) sialyl linkages of N -glycans by methylation and GC/MS analysis. Carbohydr Res 1998, 311: 51-59. 10.1016/S0008-6215(98)00196-7CrossRefPubMed
37.
go back to reference Takemoto DK, Skehel JJ, Wiley DC: A surface plasmon resonance assay for the binding of influenza virus hemagglutinin to its sialic acid receptor. Virology 1996, 217: 452-458. 10.1006/viro.1996.0139CrossRefPubMed Takemoto DK, Skehel JJ, Wiley DC: A surface plasmon resonance assay for the binding of influenza virus hemagglutinin to its sialic acid receptor. Virology 1996, 217: 452-458. 10.1006/viro.1996.0139CrossRefPubMed
38.
go back to reference Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y: Avian flu: influenza virus receptors in the human airway. Nature 2006, 440: 435-436. 10.1038/440435aCrossRefPubMed Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y: Avian flu: influenza virus receptors in the human airway. Nature 2006, 440: 435-436. 10.1038/440435aCrossRefPubMed
39.
go back to reference Davtyan TK, Hakobyan IS, Muradyan RE, Hovhannisyan HG, Gabrielyan ES: Evaluation of amino acids as mediators for the antibacterial activity of iodine-lithium-alpha-dextrin in vitro and in vivo . J Antimicrob Chemother 2007, 59: 1114-1122. 10.1093/jac/dkm094CrossRefPubMed Davtyan TK, Hakobyan IS, Muradyan RE, Hovhannisyan HG, Gabrielyan ES: Evaluation of amino acids as mediators for the antibacterial activity of iodine-lithium-alpha-dextrin in vitro and in vivo . J Antimicrob Chemother 2007, 59: 1114-1122. 10.1093/jac/dkm094CrossRefPubMed
40.
go back to reference Takahashi T, Murakami K, Nagakura M, Kishita H, Watanabe S, Honke K, Ogura K, Tai T, Kawasaki K, Miyamoto D, et al.: Sulfatide is required for efficient replication of influenza A virus. J Virol 2008, 82: 5940-5950. 10.1128/JVI.02496-07PubMedCentralCrossRefPubMed Takahashi T, Murakami K, Nagakura M, Kishita H, Watanabe S, Honke K, Ogura K, Tai T, Kawasaki K, Miyamoto D, et al.: Sulfatide is required for efficient replication of influenza A virus. J Virol 2008, 82: 5940-5950. 10.1128/JVI.02496-07PubMedCentralCrossRefPubMed
41.
go back to reference Saha RK, Takahashi T, Suzuki T: Glucosyl hesperidin prevents influenza a virus replication in vitro by inhibition of viral sialidase. Biol Pharm Bull 2009, 32: 1188-1192. 10.1248/bpb.32.1188CrossRefPubMed Saha RK, Takahashi T, Suzuki T: Glucosyl hesperidin prevents influenza a virus replication in vitro by inhibition of viral sialidase. Biol Pharm Bull 2009, 32: 1188-1192. 10.1248/bpb.32.1188CrossRefPubMed
42.
go back to reference Suzuki T, Sometani A, Yamazaki Y, Horiike G, Mizutani Y, Masuda H, Yamada M, Tahara H, Xu G, Miyamoto D, et al.: Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection. Biochem J 1996,318(Pt 2):389-393.PubMedCentralCrossRefPubMed Suzuki T, Sometani A, Yamazaki Y, Horiike G, Mizutani Y, Masuda H, Yamada M, Tahara H, Xu G, Miyamoto D, et al.: Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection. Biochem J 1996,318(Pt 2):389-393.PubMedCentralCrossRefPubMed
43.
go back to reference Yamada S, Suzuki Y, Suzuki T, Le MQ, Nidom CA, Sakai-Tagawa Y, Muramoto Y, Ito M, Kiso M, Horimoto T, et al.: Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 2006, 444: 378-382. 10.1038/nature05264CrossRefPubMed Yamada S, Suzuki Y, Suzuki T, Le MQ, Nidom CA, Sakai-Tagawa Y, Muramoto Y, Ito M, Kiso M, Horimoto T, et al.: Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 2006, 444: 378-382. 10.1038/nature05264CrossRefPubMed
Metadata
Title
Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities
Authors
Nongluk Sriwilaijaroen
Prapon Wilairat
Hiroaki Hiramatsu
Tadanobu Takahashi
Takashi Suzuki
Morihiro Ito
Yasuhiko Ito
Masato Tashiro
Yasuo Suzuki
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2009
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-6-124

Other articles of this Issue 1/2009

Virology Journal 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.